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Background: By the end of 2009 an estimated 2.5 million children worldwide were living with HIV-1, mostly as a
consequence of vertical transmission, and more than 90% of these children live in sub-Saharan Africa. In 2008 the
World Health Organization (WHO), recommended early initiation of Highly Active Antiretroviral Therapy (HAART) to
all HIV infected infants diagnosed within the first year of life, and since 2010, within the first two years of life,
irrespective of CD4 count or WHO clinical stage. The study aims were to describe implementation of EID programs
in three Tanzanian regions with differences in HIV prevalences and logistical set-up with regard to HIV DNA testing.
Methods: Data were obtained by review of the prevention from mother to child transmission of HIV (PMTCT)
registers from 2009–2011 at the Reproductive and Child Health Clinics (RCH) and from the databases from the Care
and Treatment Clinics (CTC) in all the three regions; Kilimanjaro, Mbeya and Tanga. Statistical tests used were
Poisson regression model and rank sum test.
Results: During the period of 2009 – 2011 a total of 4,860 exposed infants were registered from the reviewed sites,
of whom 4,292 (88.3%) were screened for HIV infection. Overall proportion of tested infants in the three regions
increased from 77.2% in 2009 to 97.8% in 2011. A total of 452 (10.5%) were found to be HIV infected (judged by
the result of the first test). The prevalence of HIV infection among infants was higher in Mbeya when compared to
Kilimanjaro region RR = 1.872 (95%CI = 1.408 – 2.543) p < 0.001. However sample turnaround time was significantly
shorter in both Mbeya (2.7 weeks) and Tanga (5.0 weeks) as compared to Kilimanjaro (7.0 weeks), p=<0.001. A
substantial of loss to follow-up (LTFU) was evident at all stages of EID services in the period of 2009 to 2011.
Among the infants who were receiving treatment, 61% were found to be LFTU during the review period.
Conclusion: The study showed an increase in testing of HIV exposed infants within the three years, there is large
variations of HIV prevalence among the regions. Challenges like; sample turnaround time and LTFU must be
overcome before this can translate into the intended goal of early initiation of lifelong lifesaving antiretroviral
therapy for the infants.
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By the end of 2009 an estimated 2.5 million children
worldwide were living with Human Immunodeficiency
Virus −1 (HIV-1), mostly as a consequence of vertical
transmission, and more than 90% of these children live in
sub-Saharan Africa [1]. Without any therapeutic interven-
tion approximately one third of HIV infected infants will* Correspondence: mercy_chiduo@yahoo.com
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reproduction in any medium, provided the ordie before the age of one year and half will not survive
until their second birthday [2]. Studies have shown a re-
markable increase in survival if HIV-infected children
have access to early diagnosis and treatment [3].
HIV in Tanzania is a generalized epidemic, by early
2008 it was estimated that 1.3 million people in
Tanzania mainland were living with HIV and that 10%
of them were children (below 18 yrs); i.e. about 130,000
[4]. In 2007 – 2008 the HIV prevalence in the age group
15 – 49 years was reported to be 5.7% [5], which was 1.3
lower relative to the 2003–2004 survey [6]. During theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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has stabilized around 6% [7].
HIV can be transmitted from a mother to her child during
pregnancy, at childbirth and through breastfeeding. Almost
all infections in infants can be avoided by timely delivery of
effective interventions to prevent mother-to-child transmis-
sion. The Tanzanian national guidelines states that all infants
who are exposed to HIV should be tested for HIV-infection,
even if their mothers received anti-retroviral treatment
(ART) for Prevention of Mother- to- Child Transmission
(PMTCT) [8]. Services included in the PMTCT program
are counseling and testing of pregnant women, provision of
ART for prevention of mother to child transmission of HIV,
counseling and support for safe infant feeding practices,
family planning and referral to Care and Treatment Centers
(CTC) for the infant.
In 2004, the Tanzanian Ministry of Health and Social
Welfare (MoHSW) in collaboration with stakeholders
started HIV care and treatment services [8]. Within the last
years there has been increasing availability of antiretroviral
treatments (ART) for adults and children. However, by De-
cember 2008 only 13,400 (32%) of the 42,000 children esti-
mated to be eligible for ART were receiving treatment [8].
In 2008 the World Health Organization (WHO),
recommended early initiation of Highly Active Anti-
retroviral Therapy (HAART) to all HIV infected in-
fants diagnosed within the first year of life, and since
2010, within the first two years of life, irrespective of
CD4 count or WHO clinical stage [9].
The Tanzanian MoHSW in collaboration with devel-
opment partners, initiated establishment of laboratory
capacity and training of laboratory and Reproductive
and Child Health (RCH) personnel as part of scaling
up PMTCT services. Guidelines were developed for
early infant diagnosis (EID) of all 4–6 weeks old HIV
exposed infants using dried blood spots (DBS), and for
early initiation of ART. The goal of EID of HIV is to
identify HIV-infected infants early prior to the devel-
opment of clinical diseases in order to provide them
with life-saving treatment including ART with the aim
of reducing morbidity and mortality. This is being
done by collecting DBS, sending them to the zonal la-
boratories and results are later handled over to the par-
ents. Four zonal laboratories located at Muhimbili
National Hospital (MNH), Mbeya Referral Hospital,
Kilimanjaro Christian Medical Centre (KCMC) and
Bugando Hospitals were equipped to perform EID of
HIV using deoxyribonucleic acid – polymerase chain
reaction (DNA-PCR) testing. By June 2009 there were
507 sites providing EID services in Tanzania [8].
EID requires capacity, coordination and management
of multiple health structures as well as significant logis-
tical, financial and human investments. This raises con-
cern regarding whether existing national programs areeffective in identifying HIV exposed and HIV-infected in-
fants and referring them to care and treatment services.
The study aim was to describe implementation of EID
programs in three Tanzanian regions (Kilimanjaro, Mbeya
and Tanga) with differences in HIV prevalence and logis-
tical set-up with regard to HIV DNA testing. The com-
pleteness of testing, reporting of test results, referral and
retention of infected children in the care and treatment
program were investigated.
Methods
Study area and population
The study was conducted in Kilimanjaro, Mbeya and
Tanga regions. The regions were chosen based on different
HIV prevalence and access to zonal laboratory services.
Kilimanjaro and Mbeya regions house their own zonal la-
boratories at Kilimanjaro Christian Medical Centre
(KCMC) and Mbeya Referral Hospital respectively. DBS
from Tanga are sent by postal couriers to KCMC for ana-
lysis. The prevalence of HIV among pregnant women is
high (12.6%) in Mbeya, compared to 4.6% and 5.9% in Kili-
manjaro and Tanga regions respectively [10]. Kilimanjaro
region has six districts and has a total area of 13,000 sq ki-
lometers with an estimated population of 1.5 million.
Mbeya Region is administratively divided into 8 districts
with an area of approx 64,000 sq kilometers and an esti-
mated population of 2.5 million. Tanga region covers an
area of 27,000 sq kilometers with an estimated population
of 1.6 Million and has 8 districts.
Ethical consideration
Access to the data was provided by the ethical clearance
provided by the Tanzanian Medical Research Coordinating
Committee of the National Institute for Medical Research
(NIMR) and District Medical Officers of respective health
facilities.
Data collection
Data were obtained by review of the PMTCT registers
from 2009–2011 at the RCH clinics and from the data-
bases from the CTCs in all district hospitals in the three
regions; Kilimanjaro, Mbeya and Tanga. For districts with-
out a district hospital, data were collected from health
facilities designated/used in place of district hospitals. All
data were aggregated on monthly basis.
The following data were extracted; number of pregnant
women tested for HIV during the study period (pregnant
women known to be HIV positive were not retested in suc-
cessive pregnancies during the study), number of women
testing positive for HIV antibodies, number of deliveries
(total number of infants delivered during the study period),
number of exposed infants (infants born to HIV-infected
mothers) registered at the RCHs, number of infants tested
among the registered, number of infants with positive HIV
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proportion of infected infants referred to CTCs, proportion
of infants who reported to and retained at the CTCs. Age
at which the infants were tested together with the date
when the results were received at the RCH in order to cal-
culate the sample turnaround time were collected. Infor-
mation on referrals, treatment initiation and retention of
infants to care and treatment services were obtained from
the CTC databases.
Statistical analysis
Data were entered into MS Access 2003 database and ana-
lyses were done using STATA version 11 and R version
2.15.1 statistical software packages. Exposed infants were
defined as infants born to mothers confirmed to be
infected with HIV, while proportion of infected infant was
defined as number of HIV positive infants (single positive
HIV DNA test) divided by total number of exposed infants
tested for HIV infection. Sample turn-around time was
calculated as the number of days from sample collection,
to the date results were received at the clinic. Number of
HIV positive infants was used as a denominator in calcu-
lating the proportions of the infants referred and reported
to CTC as well as infants who initiated treatment and
retained at the CTC. Poisson regression model was fitted
to compare rates of HIV infection across the sites. Rank
sum test was used to compare median age at testing and
turnaround time for test results and results were reported




Table 1 shows the general information of the reviewed
regions. Thirty-seven percent of births in Kilimanjaro
region took place at the district hospitals, while in
Tanga and Mbeya, 36.0% and 20.0% of pregnant women
delivered at the district hospitals respectively. Tanga re-
gion was having the highest coverage of health facilities
(Places providing health care including hospitals, health
centers, dispensaries and clinics) with PMTCT services
compared to Kilimanjaro and Mbeya; however, it had
the lowest coverage of health facilities providing EID
services.Table 1 Distribution of births, HIV prevalence and HIV service
study regions
Regions Population Total number
of births




Kilimanjaro 1,640,087 22,646 8,478(37.4) 1.3 (95%
Mbeya 2,707,410 69,956 13,813(20.0) 10.4 (95%
Tanga 2,045,205 44,263 15,891(36.0) 3.8 (95%
*Pooled data for 2009–2011.Prevalence of HIV infection among pregnant women
During the period 2009 – 2011 a total of 45,399 pregnant
women were tested for the first time and 3,324 (7.3%)
were HIV infected. The highest prevalence of HIV infec-
tion among pregnant women was found in Mbeya 10.2%,
while the lowest was observed in Kilimanjaro region
(1.3%), Table 1.
Exposed infants registered and tested at RCH clinics
During the period of 2009 – 2011 a total of 4,860 exposed
infants were registered from the reviewed sites, of whom
4,292 (88.3%) were screened for HIV infection. Proportion
of exposed infants tested was high (>99%) in Kilimanjaro
and Mbeya, while in Tanga only 67.6% of the HIV-exposed
infants were tested. Moreover, the proportion of tested in-
fants in the three regions increased during the reviewed
period from 77.2% in 2009 to 91.5% in 2010 and 97.8% in
2011. Among the infants who were tested, a total of 452
(10.5%) were found to be HIV infected (judged by the result
of the first test). The prevalence of HIV infection among in-
fants was two folds higher in Mbeya than in Kilimanjaro re-
gion (RR = 1.872, p < 0.001), Table 2. The HIV infection
rate among infants was lower in Tanga region, but the dif-
ference was not statistically significant (p = 0.110). The risk
of infection among the exposed infants was slightly lower
in 2010 although it was not significant (p = 0.071) com-
pared to 2009, Table 2.
Regional specific infection rates by year are as shown in
Figure 1. It was observed that the proportion of exposed
infants (number of exposed infants to the total number of
deliveries) was decreasing in Tanga region while in the
other regions it was stable. Furthermore, the proportion of
HIV-DNA positive infants was decreasing in Kilimanjaro
and Mbeya regions, while it was increasing in Tanga re-
gion consecutively between year 2009 and 2011.
Age at first EID testing and turnaround time of test
results
The median age of infants at first EID testing was signifi-
cantly higher in Mbeya (8.57 weeks) and Tanga (7.95 weeks)
when compared to Kilimanjaro region (5.6 weeks), p <
0.001. Furthermore, the median ages at testing in Mbeya
and Tanga regions were higher than that recommended in










CI: 1.10 - 1.56) 302 227 (75.2) 81/227 (36.0)
CI: 10.04–10.72) 355 269 (76.0) 169/269 (63.0)
CI: 3.40 - 4.27) 270 238 (88.1) 29/238 (12.2)
Table 2 Risk of HIV infection between the reviewed sites





Region -Kilimanjaro 51 (7.47) 1
-Mbeya 337 (13.84) 1.872 1.408 - 2.543 <0.001
-Tanga 64 (5.45) 0.737 0.508 - 1.075 0.110
Year - 2009 161 (12.64) 1
−2010 135 (9.21) 0.808 0.641 - 1.017 0.070
−2011 156 (10.10) 0.877 0.702 - 1.097 0.250
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Kilimanjaro region consistently had the lowest median test-
ing age, Figure 2.
The proportion of mothers who returned for the test re-
sults was high within the three regions with Kilimanjaro
having 99%, followed by Tanga and Mbeya with 95% and
91% respectively. Table 3, shows that the turnaround time
was significantly shorter in both Mbeya (2.7 weeks) and
Tanga (5.0 weeks) as compared to Kilimanjaro (7.0 weeks),
p < 0,001. The turnaround time has similar decreasing pat-
tern across the years like age at first testing for Kilimanjaro
and Tanga, however in Mbeya region the turnaround time
increased slightly during the study period, Figure 3.Referral and retention of infants in CTCs
Overall, the proportion of HIV infected infants referred to
CTC was higher in Kilimanjaro (95.5%) and Mbeya
(99.2%) than in Tanga (71.4%). Between 2009 and 2011
these proportions were almost the same (>95%) in Kili-
manjaro and Mbeya, while in Tanga region, the propor-
tion was lowest (<50%) in 2010, but increased to over 95%
in 2011. Among the infants who reported to the CTC in
Kilimanjaro region almost all started ART; in 2009 about
41% of the HIV infected infants reported to CTC and all
of them initiated treatment, the trend was the same in
2010 and 2011, Figure 4. The figure shows that the pro-
portion of infants reporting to CTC, initiating and being




















Figure 1 Proportion of HIV exposed and HIV DNA positive Infants inacross the years, a similar pattern was found in Tanga be-
tween 2010 and 2011.
Regarding retention of infants under treatment, in 2011
the proportion of infants who were still on treatment was
higher than that of 2009, with Mbeya having 55.0%, Tanga
with 47.6%, and Kilimanjaro 40.0% of the infants. Mbeya
region consistently performed better in retaining infants
under treatment. None of the infants who started treat-
ment in 2009 were found to be on treatment during the
time of review 2012 in Tanga region, while in Kilimanjaro
23.0% and in Mbeya 25.0% of the infants were still on
treatment, Figure 4.Loss to follow –up
A substantial of loss to follow-up (LTFU) was evident at all
stages of EID services in the period of 2009 to 2011. Thirty-
one percent of the HIV infected infants did not report to
the CTCs, Figure 4. Among the infants who were receiving
treatment during the study period, 61% were basically not
on treatment during the review period, Figure 4.Discussion
This study describes the implementation of EID program
in three regions of Tanzania, with the main focus on the
completeness of HIV testing, delivery of test results, refer-
rals and retention of infected infants in the CTCs. There
are four main findings from the study; first, the proportion
of exposed infants being tested by DBS HIV testing in-
creased during the study period 2009–11, second, the age
at first testing and sample turn-around time decreased,
third, the large variation between regions within the coun-
try and lastly the rate of loss to follow up at all stages of
EID services is still high.
The study observed the number of pregnant women
tested for HIV at the RCH was low compared to the num-
ber of deliveries at the district hospitals. This is due to the
fact that data for HIV testing were obtained at the RCH
while delivery data were obtained at the delivery wards.
























Figure 2 Age at first EID testing among the three regions.
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delivery [8] but their results were combined to those in
RCH clinics.
The prevalence of HIV among pregnant women tested
was lower than that reported in the National HIV & AIDS
surveillance [10]. However, in line with National Surveil-
lance data we found that the HIV prevalence was consist-
ently higher in Mbeya (10.2%) relative to the other two
regions of Tanga with 3.8% and Kilimanjaro with 1.3%.
The observed decrease in HIV prevalence maybe due to
the effect of scaling-up programs on primary prevention
of HIV among women of reproductive age [8]. Reports
from sub-Saharan Africa has indicated a similar trend of
decrease in HIV infection and these changes are attributed
to scale up of prevention measures and increased aware-
ness towards HIV infection [1].
Around 88% of exposed infants were screened with an
increase in proportion of infants tested for HIV infection
across the years, where the lowest rate of testing was below
70% in Tanga region. The observed high rate of testing is
likely to be a result of scaling-up of PMTCT program
which has been shown elsewhere to increase EID testing
[11]. We found disparity in rates of testing across the sites.Table 3 Distribution of pooled median age at testing and
turnaround time for results in the study regions
Region Median weeks 95%CI p-value
Age at testing
Kilimanjaro 5.9 5.6-6.4
Mbeya 8.6 8.0-9.0 <0.001
Tanga 8.0 7.2-8.4 <0.001
Turnaround time Kilimanjaro 7.0 6.2-7.4
Mbeya 2.7 2.7-2.9 <0.001
Tanga 4.9 4.7-5.0 <0.001This could be explained by low coverage of EID services
and the presence of a small number of laboratories which
can perform HIV DNA-PCR analysis. For example in Tanga
only 12% of HFs were providing EID services. Furthermore,
unavailability of financial resources to support shipment of
samples as well as remoteness of HF where DBS samples
were collected could also be reasons for disparity in rates of
testing.
Sample turn-around time showed great disparity between
the regions, with lowest median seen in Mbeya region. With
the initiation of EID there was no systemic transportation of
DBS from the HF to the zonal laboratories; samples were
given to the health personnel travelling to the regions where
zonal laboratories were located. The circumstances were the
same for the return of the results to the respected HF. In
order to improve EID services financial support for trans-
portation of DBS samples and results delivery to the health
facilities was provided by President’s Emergency Plan for
AIDS Relief (PEPFAR). The short turn-around time in
Mbeya might be a result of the presence of the zonal labora-
tory where the DBS samples are analyzed; secondly the la-
boratory was using automated short message services (SMS)
system to return the results to the health facilities. In Tanga
the short turn-around time observed was most likely due to
the fact that financial support for the systematic to and fro
delivery of samples using postal couriers was provided. The
use of SMS reporting was shown to shorten the turn-
around time in a Zambian study, where SMS allowed the
DBS samples results to be reported to relevant HF faster
than would have been possible by courier delivery of the re-
sults [12]. Although KCMC Laboratory is in Kilimanjaro,
turnaround time was longer in Kilimanjaro than in Mbeya
and Tanga. This might be due to lack of systematic methods
on sample transportation and results delivery. Turnaround
time reported in this study was similar to those reported









2009 2010 2011 2009 2010 2011 2009 2010 2011
Kilimanjaro Mbeya Tanga
Figure 3 Turnaround time of results among the three regions
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Kenya [14].
Approximately 11% of the exposed infants tested HIV
DNA positive on their first test. The infection rates
were varying from one region to another, where Mbeya
region had the highest rate relative to the other two re-
gions, despite being well covered by PMTCT services.
The results are consistent with what has been observed
in other studies [13-16]. The reason for higher rates
most likely a high prevalence of HIV infection among
pregnant women in Mbeya (10.4%) compared to that of
Kilimanjaro and Tanga, which ranged from 1 to 3%.
The infection rate among HIV exposed infants may de-
crease with better resourced PMTCT programs and
provision of more efficacious regimens [17].
Despite the proportion of parents/guardians who returned
for PCR test results of their infants and referral to care and
treatment services of HIV infected infant being high, the


























Figure 4 Stages of EID from RCH to CTC; proportions of HIV positive
treatment and retained at the CTC during 2009–2011.was, however, a trend of their increase in Mbeya and Tanga
in the recent years. The high LTFU prior to initiation of
treatment could have been caused by lack of awareness of
the mothers as well as stigma [18]. Scaling up of PMTCT
services with thoroughly counseling at each antenatal visit
has increased awareness to the mothers which tends to im-
prove visits to RCH of the mothers with exposed infants
[10]. These results of fewer infected infants initiating treat-
ment are similar with other studies that showed rapid in-
crease in the number of infants tested but, only 22% to 38%
of HIV infected infants initiated ART [11]. The study un-
derlines the need of establishing systematic referral mech-
anisms to ensure that HIV infected infants are enrolled in
ART programs. Such significant LTFU of HIV exposed in-
fants has been noted by other programs in sub-Saharan
Africa [13,15,17,19].
We found substantial LTFU at all stages of EID. The re-
sults are in accord with studies which reported that many















infants referred, reported to CTC, and infants who initiated
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nity discrimination were the most important reasons for
LTFU reported from a study done in western Kenya [22].
More studies needs to be carried out to identify reasons
for LTFU and ways of solving the problem.
The study has some limitations; the data used were from
the district hospitals, and were of low quality in terms of
missing important information like the reasons for LTFU
at various stages as well as lack of data for some years
which made it necessary pooling the data for analysis. The
lack of linkage between RCHs, Delivery wards and CTCs
makes it hard to investigate these issues thoroughly. These
findings points to a significant need for improving data
quality and reporting as well as means for linking data
from several different sources of routinely data collection
with the PMTCT program. Furthermore, the findings may
be reflecting the practical management of EID in a popu-
lation mostly living in areas with easy access to health
facilities; hence our findings cannot be generalized.Conclusions
The study showed an increase in testing of HIV exposed
infants within the three years. However there are still sig-
nificant challenges that must be overcome before this can
translate into the intended goal of early initiation of life-
long lifesaving antiretroviral therapy for the infected in-
fants. These challenges relate to turnaround time, LTFU
of infants at various stages of EID and in antiretroviral
treatment programs. Identifying the reasons behind these
challenges and addressing them is vital for the lives of the
infants. In scaling up PMTCT programs it is of paramount
importance to focus on linking the different services pro-
vided to optimize the identification, referral and retention
of the infected infants at centered treatment clinics.
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